119 related articles for article (PubMed ID: 38548749)
1. Overcoming radioresistance of breast cancer cells with MAP4K4 inhibitors.
Kwon YS; Lee MG; Kim NY; Nam GS; Nam KS; Jang H; Kim S
Sci Rep; 2024 Mar; 14(1):7410. PubMed ID: 38548749
[TBL] [Abstract][Full Text] [Related]
2. Acyl-CoA synthetase-4 mediates radioresistance of breast cancer cells by regulating FOXM1.
Kwon YS; Lee MG; Baek J; Kim NY; Jang H; Kim S
Biochem Pharmacol; 2021 Oct; 192():114718. PubMed ID: 34358518
[TBL] [Abstract][Full Text] [Related]
3. DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair.
Li Y; Li H; Peng W; He XY; Huang M; Qiu D; Xue YB; Lu L
Mol Med Rep; 2015 Jul; 12(1):1328-34. PubMed ID: 25815686
[TBL] [Abstract][Full Text] [Related]
4. MiR-181c suppresses triple-negative breast cancer tumorigenesis by targeting MAP4K4.
Xie D; Li S; Wu T; Wang X; Fang L
Pathol Res Pract; 2022 Feb; 230():153763. PubMed ID: 35026645
[TBL] [Abstract][Full Text] [Related]
5. Development and characterisation of acquired radioresistant breast cancer cell lines.
Gray M; Turnbull AK; Ward C; Meehan J; Martínez-Pérez C; Bonello M; Pang LY; Langdon SP; Kunkler IH; Murray A; Argyle D
Radiat Oncol; 2019 Apr; 14(1):64. PubMed ID: 30987655
[TBL] [Abstract][Full Text] [Related]
6. A new function for MAP4K4 inhibitors during platelet aggregation and platelet-mediated clot retraction.
Nam GS; Kim S; Kwon YS; Kim MK; Nam KS
Biochem Pharmacol; 2021 Jun; 188():114519. PubMed ID: 33737052
[TBL] [Abstract][Full Text] [Related]
7. MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3.
Singh SK; Kumar S; Viswakarma N; Principe DR; Das S; Sondarva G; Nair RS; Srivastava P; Sinha SC; Grippo PJ; Thatcher GRJ; Rana B; Rana A
Oncogene; 2021 Oct; 40(43):6153-6165. PubMed ID: 34511598
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines.
Todorovic V; Prevc A; Zakelj MN; Savarin M; Brozic A; Groselj B; Strojan P; Cemazar M; Sersa G
Radiat Oncol; 2019 Nov; 14(1):214. PubMed ID: 31775835
[TBL] [Abstract][Full Text] [Related]
9. 2-Methoxyestradiol, an endogenous estrogen metabolite, sensitizes radioresistant MCF-7/FIR breast cancer cells through multiple mechanisms.
Salama S; Diaz-Arrastia C; Patel D; Botting S; Hatch S
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):231-9. PubMed ID: 21392897
[TBL] [Abstract][Full Text] [Related]
10. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
11. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4.
Zhao G; Wang B; Liu Y; Zhang JG; Deng SC; Qin Q; Tian K; Li X; Zhu S; Niu Y; Gong Q; Wang CY
Mol Cancer Ther; 2013 Nov; 12(11):2569-80. PubMed ID: 24013097
[TBL] [Abstract][Full Text] [Related]
12. miR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα.
Luo M; Ding L; Li Q; Yao H
Breast Cancer; 2017 Sep; 24(5):673-682. PubMed ID: 28138801
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Role of MAP4K4 in Focal Adhesion Dynamics and Regulation of Cell Migration of Breast Cancer Cell Line MDA-MB-231.
Al-Fahad D; Al-Bedhawi M; Ateya H
Arch Razi Inst; 2023 Feb; 78(1):261-267. PubMed ID: 37312710
[TBL] [Abstract][Full Text] [Related]
14. Silencing of Long Non-coding RNA GAS5 Suppresses Neuron Cell Apoptosis and Nerve Injury in Ischemic Stroke Through Inhibiting DNMT3B-Dependent MAP4K4 Methylation.
Deng Y; Chen D; Gao F; Lv H; Zhang G; Sun X; Liu L; Mo D; Ma N; Song L; Huo X; Yan T; Zhang J; Luo Y; Miao Z
Transl Stroke Res; 2020 Oct; 11(5):950-966. PubMed ID: 31997156
[TBL] [Abstract][Full Text] [Related]
15. Profiling global kinome signatures of the radioresistant MCF-7/C6 breast cancer cells using MRM-based targeted proteomics.
Guo L; Xiao Y; Fan M; Li JJ; Wang Y
J Proteome Res; 2015 Jan; 14(1):193-201. PubMed ID: 25341124
[TBL] [Abstract][Full Text] [Related]
16. Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells.
Yang N; Wang Y; Hui L; Li X; Jiang X
J Histochem Cytochem; 2015 Sep; 63(9):721-33. PubMed ID: 26001828
[TBL] [Abstract][Full Text] [Related]
17. MAP4K4 mediates the SOX6-induced autophagy and reduces the chemosensitivity of cervical cancer.
Huang H; Han Q; Zheng H; Liu M; Shi S; Zhang T; Yang X; Li Z; Xu Q; Guo H; Lu F; Wang J
Cell Death Dis; 2021 Dec; 13(1):13. PubMed ID: 34930918
[TBL] [Abstract][Full Text] [Related]
18. Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4.
Golforoush PA; Narasimhan P; Chaves-Guerrero PP; Lawrence E; Newton G; Yan R; Harding SE; Perrior T; Chapman KL; Schneider MD
Sci Rep; 2020 Jul; 10(1):12060. PubMed ID: 32694738
[TBL] [Abstract][Full Text] [Related]
19. Targeting epidermal growth factor receptor-associated signaling pathways in non-small cell lung cancer cells: implication in radiation response.
Choi EJ; Ryu YK; Kim SY; Wu HG; Kim JS; Kim IH; Kim IA
Mol Cancer Res; 2010 Jul; 8(7):1027-36. PubMed ID: 20587532
[TBL] [Abstract][Full Text] [Related]
20. MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance.
Gao X; Chen G; Gao C; Zhang DH; Kuan SF; Stabile LP; Liu G; Hu J
Mol Oncol; 2017 Jun; 11(6):628-639. PubMed ID: 28306189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]